Increased temporal patterns in choice responding and altered cognitive processes in schizophrenia and mania

Psychopharmacology

Volumn 172, Issue 2, 2004, Pages 211-219

  Lyon, Melvin ^a   Kemp, Aaron S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clozapine; Dopamine receptors; Magnusson THEME program; Mania; Schizophrenia; Time patterns

Indexed keywords

CLOZAPINE; DOPAMINE RECEPTOR;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FACTORIAL ANALYSIS; FEMALE; HUMAN; LEARNING; MALE; MANIA; NEUROPHYSIOLOGY; PRIORITY JOURNAL; REINFORCEMENT; RESPONSE TIME; SCHIZOPHRENIA; STEREOTYPY; STIMULUS RESPONSE; TEMPORAL SUMMATION;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHOICE BEHAVIOR; COGNITION; FEMALE; HUMANS; MALE; REACTION TIME; SCHIZOPHRENIA; TIME FACTORS;

EID: 1642317676     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1646-0     Document Type: Article

References (44)

1. American Psychiatric Association (1987) DSM-III-R: Diagnostic and statistical manual of mental disorders, 3rd edn., revised. APA, Washington
2. American Psychiatric Association (1998) DSM-IV TR: Diagnostic and statistical manual of mental disorders, 4th edn., revised. APA, Washington
3. Anonymous (1999) SAS/STAT user's guide, version 8. SAS Institute, Inc., Gary, NC
4. Baldwin AE, Sadeghian K, Kelley AE (2002) Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex. J Neurosci 22:1063-1071
5. Berrettini WH (2000) Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 48:531-538
6. Bleuler E (1910/1950) Dementia praecox. International University Press, New York
7. Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-186
8. Carlsson A (1995) Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharmacol 3[Suppl 10]: 21-28
9. Carlsson A (2001) A paradigm shift in brain research. Science 294:1021-1024
10. Carlsson M, Carlsson A (1989) Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine. J Neurotransm 1:317-322
11. Chen L, Yang CR (2002) Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex. J Neurophysiol 87:2324-2336
12. Cobb WS, Abercrombie ED (2002) Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol. J Neurosci 22:1407-1413
13. Cooper SJ, Dourish CT (1990) Neurobiology of stereotyped behavior. Clarendon Press, Oxford
14. 1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in Java monkeys. Neuropsychopharmacology 2:191-199
15. Fenu S, Bassareo V, Di Chiara G (2001) A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning. J Neurosci 21:6897-6904
16. Friedman JI, Temporini H, Davis KL (1999) Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biol Psychiatry 45:1-16
17. Frith CD, Done DJ (1983) Stereotyped responding by schizophrenic patients on a two-choice guessing task. Psychol Med 13:779-786
18. Gerlach J, Peacock L (1995) New antipsychotics: the present status. Int Clin Psychopharmacol 10[Suppl 3]:39-48
19. Grube BS, Bilder RM, Goldman RS (1998) Meta-analysis of symptom factors in schizophrenia. Schizophr Res 31:113-120
20. 67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry 57:1061-1069
21. 2 antagonist haloperidol. Behav Neurosci 115:1291-1300
22. 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 50:873-883
23. Keefe RSE, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M (2003) Neurocognitive assessment in the clinical antipsychotic trials of intervention effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull 29:45-55
24. Kelso JAS (1997) Dynamic patterns: the self-organization of brain and behavior. MIT Press, Cambridge
25. Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM (1992) Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol 15:488-500
26. Konradi C, Heckers S (2001) Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry 50:729-742
27. Kreipke CW, Walker PD (2002) NMDA antagonism and D1-receptor stimulation synergistically induces c-Fos within the striatum and produces hyperlocomotor, stereotypical, and hypersensitive behavior. Program No. 165.11, Society for Neuroscience, Washington, DC
28. 4, receptors in the striatum without the involvement of action potentials. J Neurosci 20:6666-6671
29. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R (1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56-72
30. Lyon M, Robbins TW (1975) The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Essman W, Valzelli L (eds) Current developments in psychopharmacology, 2nd edn. Spectrum Publications, Inc., New York, pp 79-163
31. Lyon M, Lyon N, Magnusson MS (1994) The importance of temporal structure in analyzing schizophrenic behavior: some theoretical and diagnostic implications. Schizophr Res 13:45-56
32. Lyon N, Gerlach J (1988) Perseverative structuring of responses by schizophrenic and affective disorder patients. J Psychiatry Res 21:261-277
33. Magnusson MS (1996) Hidden real-time patterns in intra-and inter-individual behavior: description and detection. Eur J Psychol Assess 12:112-123
34. Magnusson MS (2000) Discovering hidden time patterns in behavior: T-patterns and their detection. Behav Res Meth Instrum Comput 12:93-110
35. Overall J, Gorham D (1962) The brief psychiatric rating scale. Psychol Reports 10:799-812
36. Paulus MP, Braff DL (2003) Chaos and schizophrenia: does the method fit the madness? Biol Psychiatry 53:3-11
37. Peacock L, Gerlach J (1999) New and old antipsychotics versus clozapine in a monkey model: adverse effects and anti-amphetamine effects. Psychopharmacology 144:189-197
38. 1 receptor actions. Biol Psychiatry 50:501-509
39. 2 antagonist treatment in Cebus apella monkeys: anti-amphetamine effects and extrapyramidal side effects. Neuropsychopharmacology 20:35-43
40. Randrup A, Munkvad I, Fog R (1980) Mental and behavioral stereotypies elicited by stimulant drugs: relation to the dopamine hypothesis of schizophrenia, mania, and depression. Abstracts of the 12th Congress of Collegium Internationale Neuro-Psychopharmacologicum, Gothenburg, Sweden, 22-26 June 1980. Pergamon Press, New York
41. Snyder DM (1991) An alternative view of schizophrenic cognition. Speculations Sci Technol 14:211-217
42. Svensson A, Carlsson ML, Carlsson A (1992) Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to motor control. J Neural Transm 88:235-240
43. Svensson A, Carlsson ML, Carlsson A (1994) Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone. Prog Neuropsychopharmacol Biol Psychiatry 18:1203-1218
44. Szeszko PR, Bilder RM, Dunlop JA, Walder DJ, Lieberman JA (1999) Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases. Biol Psychiatry 45:680-686